Flo Health Receives More than $200M Investment from General Atlantic
Summary
With over 120 doctors and health experts, the platform offers curated cycle and ovulation tracking. Users can monitor over 70 symptoms and access various features designed to enhance their understanding and management of their health. Flo’s partnership with General Atlantic will help position the company for its next phase of growth, with a focus on expanding into new user segments including perimenopause and menopause, enhancing its tech-driven health insights, and pursuing strategic expansion opportunities. To support these goals, Flo intends to increase R&D headcount with investments in talent across its global offices in Europe and North America. Flo also intends to leverage General Atlantic’s expertise in scaling companies at the intersection of consumer technology, healthcare, and subscription business models.